Tolerance, physical dependence, and Δ9-THC-like interoceptive effects of cannabinol in mice.
S. Vanegas, J. Marusich, J. Maturano, D. Sarlah, S. G. Kinsey
Drug and Alcohol Dependence September 1, 2026 DOI: 10.1016/j.drugalcdep.2026.113341 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical animal study Peer reviewed |
|---|---|
| Population | Adult C57BL/6 mice |
| Interventions | Cannabinol (CBN) rimonabant WIN 55 212-2 THC |
| Duration | CBN administered twice daily for five days; withdrawal assessed on the sixth day |
| Measures | Tetrad battery, tail suspension test, drug discrimination |
| Topics | Addiction Cannabis |
| Key points | Repeated CBN administration in mice produced tolerance to cannabimimetic effects and physical dependence, evidenced by rimonabant-precipitated withdrawal. CBN fully substituted for THC in discrimination tests, and CBN plus THC attenuated THC's psychoactive effects. |
Abstract
Background: AND PURPOSE Cannabinoids, including Δ9-tetrahydrocannabinol (THC) and synthetic CB1 agonists elicit acute psychotropic effects that undergo tolerance with repeated exposure. In contrast, the effects of prolonged cannabinol (CBN) use are unknown. This study examined (1) the effects of repeated CBN administration on classic cannabimimetic outcomes, (2) whether these effects undergo tolerance or induce physical dependence, and (3) the THC-like discriminative stimulus effects of CBN, including whether CBN alters THC's discriminative stimulus. EXPERIMENTAL APPROACH Adult C57BL/6 mice were administered CBN twice daily for five days and tested in the tetrad battery to measure tolerance. On the sixth day, rimonabant was administered and somatic signs of withdrawal (i.e., head twitches and paw tremors) and struggling in the tail suspension test were assessed. Cross-tolerance to the CB1/CB2 agonist WIN 55,212-2 was also assessed in mice repeatedly administered CBN. A separate cohort of mice was trained to discriminate THC from vehicle. KEY RESULTS Mice displayed tolerance to CBN-induced catalepsy, antinociception, and hypothermia. Cannabimimetic effects of WIN 55,212-2 were attenuated in CBN-treated mice, indicating cross-tolerance. Similarly, rimonabant induced somatic withdrawal signs and increased struggling in CBN-treated mice. Finally, CBN fully substituted for THC. Although rimonabant substantially lowered the psychoactive effects of THC, the specific dose tested was less effective in lowering CBN's psychoactive effects. Administration of CBN plus THC also attenuated THC's psychoactive effects.
Conclusion: AND IMPLICATIONS These data indicate that repeated CBN administration induces tolerance and physical dependence and that CBN reduces THC's psychoactive effects.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Repeated cannabinol administration produced tolerance to cannabimimetic effects and physical dependence evidenced by rimonabant-precipitated withdrawal, and cannabinol fully substituted for THC in discrimination tests.
Synthesized
Comparable studies
Other preclinical and animal studies on cannabis for addiction, most cited first.